Particular date of Commendation: April 17, 2007
Society: Sanofi Pasteur Iraqi National Congress.
Discourse for: Prevention of H5N1 Flu (Avian Influenza)
The U.S. Food and Drug Presidential term (FDA) has licensed Influenza Virus Vaccinum, H5N1, the first avian influenza vaccinum for world in the U.S.
Sanofi louis Pasteur, in coaction with the National Institutes of Health, submitted a Biologics Permission Application to the Food and Drug Administration for this H5N1 vaccine. The licensure serves as a first base key dance step in achieving the government’s goal of stockpiling vaccinum intended to protect those who are at increased risk of exposure to the H5N1 influenza virus contained in the vaccine during the early stages of a pandemic.
The licensure of this vaccinum was based on a clinical test conducted by the National Institute of Allergy and Infectious Diseases. This trial evaluated the safety and ability to generate an immune response of this vaccine when administered in two 90 µg/ml doses in healthy adults 18 through 64 long time. The bailiwick, which was completed in 2005, showed that the vaccine elicited an immune response against the H5N1 virus and was associated with meek side effects.
Source: Sanofi Pasteur INC.
Grippe Virus Vaccine, H5N1 - Questions and Answers
What is the Food and Drug Governance (FDA) announcing?
FDA is announcing the licensure of the first gear vaccine in the Joined States for humans against the H5N1 influenza virus, commonly referred to as avian influenza or “bird flu.” This inactivated flu virus vaccinum is indicated for immunization of persons 18 through 64 age of age who ar at increased risk of exposure to the H5N1 influenza virus subtype contained in the vaccine. This vaccine is derived from the A/Vietnam/1203/2004 influenza virus. The vaccine is manufactured by sanofi pasteur INC. of Swiftwater, PA and has been purchased by the federal government for inclusion inside the Nation’s National Stockpile.
The favourable reception and availability of this vaccine is an important step in enhancing the Nation’s preparedness against a possible pandemic and enhances our ability to protect those at increased risk of exposure to the H5N1 virus.
What is avian grippe?
Avian influenza - the “fowl flu” - is a virus that infects wild birds (e.g., ducks and gulls) and domestic poultry (e.g., chickens and turkeys). There are numerous different strains of avian flu; however, most do not cause unwellness in people. Only influenza A viruses naturally infect birds. Wild birds ar the natural host for all subtypes of grippe A virus. In general, wild birds do not get ill when they are infected with flu virus, just some avian viruses tooshie cause serious disease and death in wild birds. However, domestic poultry, such as turkeys and chickens, can incur very sick and die from avian influenza. H5N1 is a newer, more recent form of avian influenza, and is currently the master cause of concern among the scientific and aesculapian community with regard to its potency to grounds a pandemic. The H5N1 strain butt infect birds, other animals and people.
What is an flu pandemic?
An influenza pandemic is a global irruption of disease that occurs when a new flu virus appears in the human population, causes sober illness, and then spreads easily from person to person. It can broom across a country and around the world in a identical short time. Like the seasonal influenza many citizenry get every year, pandemic influenza volition probably spread by septic people coughing or sneezing or by touching something with the influenza computer virus on it and then touching their mouth or nose. Unlike seasonal flu, people testament have little immunity to the virus that causes a pandemic. An influenza pandemic testament likely campaign more severe illness, regular death, and affect more people than seasonal influenza.
It is difficult to predict when the future influenza pandemic will occur or how severe it will be. In the past century, pandemics occurred in 1918-1919, 1957-1958 and 1968-1969.
The H5N1 strain of the avian flu virus has caused the largest number of reported cases of severe disease and death in humankind of any avian grippe viruses and is a potential prospect for starting the next pandemic.
Wherever and whenever an influenza pandemic starts, everyone around the existence is at risk for getting the disease. Countries might delay arrival of the virus through measures such as border closures and journey restrictions, just these measures are non likely to totally protect the population.
Has anyone been diagnosed with avian influenza?
There have not been whatever human cases of avian influenza in the United States or North United States, but there have been cases in other parts of the world such as Asia and Africa. According to statistics provided by the World Health Organization, from 2003 through April 11, 2007, there have been 291 laboratory-confirmed cases in humans, of whom, 172 died. Each additional case provides the virus an opportunity to improve its ability for human-to-human transmission and develop into a pandemic straining. But good now, thither is no pandemic flu in the world.
Is avian influenza more serious than seasonal worker influenza?
Yes. H5N1 or avian grippe has some of the standard seasonal worker influenza symptoms such as high febrility, headache, and muscle aches, but people quickly become seriously ill and pneumonia, difficulty respiration, and multi-organ failure have been common among people who ingest been afflicted with H5N1 influenza.
How well does the grippe virus vaccine, H5N1, make?
One multi-center, randomized, double-blinded, placebo-controlled, dose-ranging study in healthy adults, 18 to 64 years of age, investigated the safety and immunogenicity of the vaccine. A add up of 103 healthy adults received a 90 mcg dose of the vaccinum by injection, followed by another 90 microgram dosage, 28 years later. In addition, on that point were approximately another 300 healthy adults who standard the vaccine at doses lower than 90 micrograms and a total of 48 wHO received placebo by injection.
Of the various doses tested, the study showed that the 90 microgram dose had the better immune response, meaning that at this particular sTD, the vaccinum induced the most antibodies in the blood against the H5N1 influenza computer virus strain. The 90 mcg two-dose regimen produced levels of antibodies expected to reduce the risk of getting H5N1 influenza in 45% of those world Health Organization received it. Although the remaining individuals did non develop this level of antibody, stream scientific info on other influenza vaccines, suggests that less than optimal antibody levels english hawthorn still have the electric potential to help reduce disease severity and influenza-related hospitalizations, and deaths.
Why didn’t the clinical trial include more citizenry?
FDA recognizes that a limited number of citizenry were studied in the clinical trial. The study was designed by the National Institutes of Health (NIH) as an exploratory study to look at the quantity of antibodies generated in humans from various doses. Because the results showed promise for providing aegis against the H5N1 influenza virus and helping with national preparedness for flu pandemic, sanofi pasteur submitted a Biologics License Diligence to Food and Drug Administration.
Although each 90 mcg dose needed to energise the immune response was twice the amount that is used in the seasonal flu vaccine, the manufacturing litigate and vaccinum formulation for the H5N1 vaccine is the same as that of sanofi pasteur’s US licensed seasonal worker vaccine, which has a long criminal record of refuge and strength.
It is fortunate to have this vaccine during this “inter-pandemic” phase. The benefit of having a commissioned vaccine against a potency pandemic flu virus stress, even with limited data, outweighs the risk of having no vaccine at the time of an inevitable flu pandemic.
What are the risks associated with the vaccine?
The vaccine was generally well-tolerated by the recipients in the sketch, with pain and tenderness at the injection site, headache, general ill feeling, and brawniness pain organism the almost common complaints. However, because the identification number of people studied was small, rare safety events may non have been identified, but given the potential peril of a pandemic, this is the only vaccine currently useable and its benefits outweigh its risks. In addition, sanofi pasteur has agreed to work with the U.S. government to gather extra information on the safety and potency of the vaccine should it be used in the event of a pandemic.
How will FDA monitor the safety of a pandemic influenza vaccinum if it is used?
Post-licensure monitoring of vaccinum safety involves identification of possible adverse effects of vaccination, followed by evaluation of these “signals” for a possible causal link with vaccines. Systems currently available to direct vaccine guard monitoring include the Vaccinum Adverse Event Reporting System (VAERS) and the Vaccinum Safety Datalink (VSD). Adaptation of these systems for use during a pandemic may be required. Other large machine-controlled databases of encounter and/or claims data that power be useful for pandemic influenza vaccinum safety monitoring include those of the Centers for Medicaid & Medicare Services, Veterans Personal business, Department of Defense, and private insurance groups not currently part of the VSD. The FDA and the Centers for Disease Control and Prevention (Center for Disease Control and Prevention) are evaluating these systems for potential to contribute to the monitoring of pandemic grippe vaccine safety device. If the pandemic vaccine is administered primarily through and through public health departments, a registry of vaccinees, with common identifiers allowing researchers to determine the inoculation status of those with adverse events (AE), may need to be constituted.
What if a pandemic is declared and the influenza computer virus strain of the pandemic is different than the influenza virus strain in this vaccine?
No one can portend which influenza virus subtype (strain) will cause the next pandemic. Several factors affect the effectiveness of influenza vaccines. One major factor is the level to which circulating strains and influenza vaccine strains are similar. If the pandemic virus strain is substantially different from the H5N1 virus contained in the vaccinum, it is unlikely that the existing vaccine would be effective. It is possible that the future influenza pandemic will be caused by a striving of influenza that does not belong to the H5N1 subtype. Both of these scenarios would call for development of a raw vaccine. If the influenza pandemic nervous strain turns out not to be a perfect match with the vaccine straining, it does not necessarily mean that the vaccine can’t be used; studies have shown that influenza vaccine may provide some immunity against strains that are pretty different.
The goal of pandemic preparation is to develop extra vaccines and vaccination strategies that volition be ready for use against versatile strains that have the potential to cause a pandemic.
Does the vaccine contain merthiolate?
Yes, merthiolate, a mercury containing compound, is used as a preservative in the vaccinum. Because the vaccine is supplied in a multi-dose vial; it is necessary to own a preservative to keep the growth of bacterium and fungus in the event that the vaccinum is by chance contaminated, as might occur with perennial puncture of multi-dose vials.
Will the vaccine be available to anyone world Health Organization wants it?
No, the manufacturer has stated that the vaccinum won’t be available to the populace commercially, substance it can’t be obtained from a doctor’s federal agency. It has been purchased by the federal administration for comprehension within the country’s National Stockpile, for distribution by the Department of Wellness and Human Services in case it is ever needed.
Why is the vaccine for inclusion within the National Stockpile and not being made available to all Americans?
The production capacity of the United States currently is not sufficient to make vaccine apace available for the entire population. Inclusion of this vaccine in the National Stockpile testament ensure that when it is needful, those wHO are designated as precedency recipients, will have vaccine available to them. Other vaccines are also beingness developed to meet the Nation’s necessarily against flu pandemics.
Even though it will be in the Stockpile, tin can people world Health Organization may be at risk of exposure to H5N1 influenza virus, such as travelers to infected regions of the world, poultry workers, or first-responders get the vaccine?
At this time, immunization is not recommended for populations that may be at risk of infection of exposure to H5N1 influenza virus. Through its Interagency Pandemic Vaccine Prioritization Working Mathematical group, the federal government is working to decide world Health Organization will get under one’s skin the vaccinum earliest in a pandemic.
Why does the approved indication not include children or aged?
It is not uncommon for new vaccines to be time-tested in a healthy adult population and then once further information is gathered about benefits and risks, additional testing is through in other populations such as children and the elderly. Food and Drug Administration is expecting information on these particular populations to be submitted in the near future and volition evaluate those results.
How is the vaccine administered?
It is administered as a two-dose regimen. One 90 microgram dose is given intramuscularly, in the upper arm, and a second 90 microgram cupid’s itch is granted in the same mode, 28 days later.
Is it possible to become infected with avian influenza from the H5N1 vaccine?
No. The vaccine is made from killed influenza viruses, and they cannot cause flu infection.
Will the annual shot for influenza protect people against pandemic flu?
No, stream annual influenza vaccines include three grippe viruses, A subtypes H3N2 and H1N1 viruses, and one B virus. A vaccine made from these viruses would not render protection against a unlike influenza A subtype virus (such as H5N1).
It is important to continue to convey the grippe shot every year as this is the topper way to prevent illness from the seasonal influenza virus.
Where can I get more information on avian grippe and actions that butt be taken to prepare for a pandemic?
Information can be found at www.pandemicflu.gov. This internet site provides one-stop access to U.S. Government avian and pandemic flu selective information and is managed by the Department of Health and Human Services. In addition, data can as well be establish on FDA’s website at Contraindications
None
Warnings and Precautions
History of a hypersensitvity reaction to chicken or egg proteins or serious reactions to previous grippe vaccinations.
If Guillain-Barré syndrome (GBS) has occurred inside six weeks of vaccination with flu vaccine, the decision to give Flu Virus Vaccine, H5N1, should be based on thrifty consideration of the benefits and risks.
Immunocompromised persons may have a reduced immune reception to Flu Virus Vaccine, H5N1.
Untoward Reactions
To the highest degree common (>10%) contrary reactions are pain at injection land site, headache, unease, and myodynia.
Drug Interactions
Do not mix with other vaccines in the same syringe or ampule.
Immunosuppressive therapies may reduce the immune response to Influenza Virus Vaccine, H5N1.
Use in Specific Populations
Safety and effectiveness have not been established in pregnant or lactating women, and in pediatric and geriatric populations.
Patient Direction Information
Patients, parents or guardians should be full informed by their health care supplier of the benefits and risks of immunization with Influenza Virus Vaccine, H5N1. When educating vaccine recipients and guardians regarding the potential side of meat effects, clinicians should punctuate that Influenza Virus Vaccine, H5N1, contains non-infectious particles.
Patients, parents or guardians should be instructed to report any serious inauspicious reaction to their health care supplier.
For more than information, please see Grippe Virus Vaccinum, H5N1 <a href=”http://www.fda.Mexitil
Rate it!